Gufic Biosciences is currently trading at Rs. 297.55, up by 0.75 points or 0.25% from its previous closing of Rs. 296.80 on the BSE.
The scrip opened at Rs. 298.10 and has touched a high and low of Rs. 299.50 and Rs. 297.20 respectively. So far 3312 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 339.55 on 04-Sep-2023 and a 52 week low of Rs. 177.10 on 29-Mar-2023.
Last one week high and low of the scrip stood at Rs. 307.90 and Rs. 266.45 respectively. The current market cap of the company is Rs. 2993.28 crore.
The promoters holding in the company stood at 75.00%, while Institutions and Non-Institutions held 2.36% and 22.64% respectively.
Gufic Biosciences has incorporated a subsidiary Company in India namely ‘Gufic Prime’ on November 18, 2023. Gufic Prime shall carry on the business of manufacturing, marketing, distribution and sale of pharmaceutical products. The Cost of subscription of shares would be Rs 88,000 (88,000 equity shares of face value of Rs 1 each). Gufic Prime is yet to commence its business operation.
Gufic Biosciences is engaged in diversified business viz. Pharma, Healthcare, Bio- Technology, Seeds, Herbal etc.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1521.95 |
Dr. Reddys Lab | 6279.95 |
Cipla | 1407.55 |
Zydus Lifesciences | 963.50 |
Lupin | 1640.30 |
View more.. |